Melphalan 200 mg/m2 Versus Melphalan 100 mg/m2 in Newly Diagnosed Myeloma Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00950768
Recruitment Status : Completed
First Posted : August 3, 2009
Last Update Posted : August 3, 2009
Information provided by:
Azienda Ospedaliera San Giovanni Battista